A specialist agency defining & driving value along the journey to full patient access

The problems of the world cannot possibly be solved by those whose horizons are limited by obvious realities. We need to dream of things that never were, and ask why not.
— Adapted from John F Kennedy

Our three philosophies

  • Obsessive focus on value

    From product to patient, everything we do is driven by understanding the value drivers from every perspective – company, patient, HCP and healthcare system.

  • Patient & customer-centric

    We create innovative access solutions by embedding compelling value narratives. Our Brains Trust™ and Clinesis™ Platform make deep understanding of patient and customer value drivers possible.

  • Innovative solutions at every stage of the lifecycle

    No two projects we work on are the same. We create bespoke, innovative solutions for your access needs along the full product lifecycle.

Compelling Value + Patient Narratives + The Science

= Full Patient Access

Lots of other agencies wanted to take the usual route, the difference with nzyme access was they created a bespoke solution that fitted our specific product challenge. The team co-created with us and our customers a compelling value narrative which has become the strategic backbone for everything we do
— UK Managing Director, Respiratory Business

Project types

nzyme access has expertise across a wide range of healthcare access solutions

  • Value propositions

    Co-created with our Brains Trust™ of key stakeholders, we help create compelling value propositions delivered in unique ways.

  • Expert steering committees

    Our experience of over more than 20 years has created a strong, deep network of key NHS stakeholders. We run action-based, challenging Steering Committee engagements to co-create innovative solutions.

  • Advance budget notifications

    Evidence-based and structured in an effective way to drive pre-launch engagement.

  • Whole system solutions

    Combines bespoke project types that unlock the journey to full patient access by communicating value across the whole system.

  • Patient-centric value narratives

    We start with compelling patient-centric value narratives co-created with our Brains Trust™ of key clinicians that become the strategic rudder.

  • Full-service access

    Where required, you can outsource all elements of market access and we will work with you like an internal team. We have experience doing this for emerging Biotech businesses.

  • Service improvements

    Understanding pressure points and bottlenecks within healthcare systems and redesigning those elements to improve services.

  • Pathway and service redesign

    Creating innovative pathways and services to open up full patient access, co-created with our Brains Trust™, validated and enhanced with Clinesis™ research.

  • Payer and influencer engagement

    The nzyme group is built from specialist practices. Our other two practices – educate and activate – can enable the effective engagement of payers and influences using innovative channels.

Read our “Mind The Gap” White Paper

Value is in the eye of the customer. Co-creation is a bridge to value. We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported by in-depth industry scanning.

We amplify your access efforts through tailored, flexible digital solutions

Our digital solutions

 

Interactive product decision trees


Digital interactive pathway models


Pre-launch patient warehousing models


Digital interactive value propositions


Budget impact models


To use technology to help health and care professionals communicate better and enable people to access the care they need quickly and easily when it suits them
— NHS England Digital Transformation Plan
 

nzyme access will help you partner with NHS England to realise solutions that contribute to the NHS digital transformation plan

Exceptional NHS networks and proven experience

You can count on a senior management team who are experienced in unlocking access by partnering closely with key stakeholders to unlock and leverage value drivers along the patient pathway at every stage of the product lifecycle.

  • Toby Gunner

    Chief Executive Officer

    Toby is a recognised industry thought leader responsible for originating product launch and Market Access strategies for many of the world’s top 20 pharmaceutical companies as well as emerging biotech, healthcare, and digital organisations. Toby’s incisive analytical intellect and strategic business insight have steered many of today’s market-leading pharmaceutical products to their prominent position.

  • Laura Musson

    Market Access Manager

    Laura graduated from the University of Essex with a BSc in Biological Sciences. Laura is a key member of the access & educate team. She injects her knowledge and expertise into the development of co-created omni-channel content, underpinned by her strong medical writing skills and digital acumen.

Unrivalled access to key decision makers and deep understanding of complex healthcare systems

Expect the unexpected

Key Decision Maker connections

We’ve worked tirelessly to build connections between the pharmaceutical industry and the NHS to embed real insights and drive the delivery of high-value, co-created whole-system solutions.


Shaping the future of healthcare delivery

Our access to customer insight through our Brains Trust™ and Clinesis™ platform means that everything we do is evidence-based to realise different, bespoke access solutions.


Working with and for the NHS

We believe in working with and for the NHS to realise value through delivery to them and for them.

Let’s have a conversation